Fenoglide
- Product NDC
- 52725-495
- 11-digit product format
- 527250495
- Labeler code
- 52725
- Product ID
- 52725-495_986c60c0-7d75-11e0-b654-0002a5d5c51b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fenofibrate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Shore Therapeutics, Inc
- Application
- NDA022118
- Marketing category
- NDA
- Marketing start
- 2010-11-18
- Marketing end
- 0000-00-00
- Substance
- FENOFIBRATE
- Active strength
- 120 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 193bb7da-5c03-8f95-9048-23ef403846b0 | Product name | 3 | 20250616 |
| fa35fb9a-7146-716b-13c8-bc1f60030232 | Product name | 9 | 20250114 |
| cfc78bfa-7d55-47e5-aeb7-71cd79f5ca07 | Product name | 8 | 20231212 |
| ed9d55d4-85bd-0ee7-5b4a-b705646a3a66 | Product name | 9 | 20200708 |
| 36a239c8-03fb-0083-81af-6c1afb195671 | Product name | 1 | 20140508 |
| a0296d70-ca85-018c-84e8-cf3f630976b7 | Product name | 1 | 20140508 |
| f2e3e9c8-a2f9-0cc3-a5a5-6dfd0279372a | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52725-495-07 | Fenoglide | 6 in 1 BOX | TABLET | 6 | 2 | |
| 52725-495-07 | Fenoglide | 7 in 1 BOTTLE, PLASTIC | TABLET | 7 | 2 | |
| 52725-495-90 | Fenoglide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 2 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| fenofibrate | ACTIVE INGREDIENT | U202363UOS | FENOGLIDE (FENOFIBRATE) TABLET [SHORE THERAPEUTICS, INC] | 2 | |
| fenofibrate | ACTIVE MOIETY | U202363UOS | FENOGLIDE (FENOFIBRATE) TABLET [SHORE THERAPEUTICS, INC] | 2 | |
| lactose monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | FENOGLIDE (FENOFIBRATE) TABLET [SHORE THERAPEUTICS, INC] | 2 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | FENOGLIDE (FENOFIBRATE) TABLET [SHORE THERAPEUTICS, INC] | 2 | |
| Poloxamer 188 | INACTIVE INGREDIENT | LQA7B6G8JG | FENOGLIDE (FENOFIBRATE) TABLET [SHORE THERAPEUTICS, INC] | 2 | |
| Polyethylene Glycol 6000 | INACTIVE INGREDIENT | 30IQX730WE | FENOGLIDE (FENOFIBRATE) TABLET [SHORE THERAPEUTICS, INC] | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 749802 | fenofibrate 120 MG Oral Tablet | PSN | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
| 749804 | fenofibrate 40 MG Oral Tablet | PSN | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
| 763250 | Fenoglide 120 MG Oral Tablet | PSN | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
| 763252 | Fenoglide 40 MG Oral Tablet | PSN | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
| 763250 | fenofibrate 120 MG Oral Tablet [Fenoglide] | SBD | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
| 763252 | fenofibrate 40 MG Oral Tablet [Fenoglide] | SBD | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
| 749802 | fenofibrate 120 MG Oral Tablet | SCD | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
| 749804 | fenofibrate 40 MG Oral Tablet | SCD | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
| 763250 | Fenoglide 120 MG Oral Tablet | SY | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
| 763252 | Fenoglide 40 MG Oral Tablet | SY | b38489c0-ee7b-11df-b958-0002a5d5c51b | 2 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 52725-495-07 | 52725049507 | 6 in 1 BOX | Historical |
| 52725-495-90 | 52725049590 | 90 in 1 BOTTLE, PLASTIC | Historical |